Skip to main content
Smart Investors Daily
CS

OTC · CSLLY

CSL Limited

Healthcare · Biotechnology

$30.26

Down-$0.18 (-0.59%)

Updated Aug 22, 2026, 3:46 PM

SID Score

6.3/10

Composite research score

Smart Money

46/100

Neutral

Market cap
116.24B
P/E ratio
19.02
Dividend yield
4.82%
52-week range
— – —
Volume
19.38K
Avg. volume
161.07K

Price performance

CSLLY price history

1M range · 0 trading sessions · Daily adjusted prices

CSLLY does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest CSLLY news

The latest Smart Investors Daily articles mentioning CSLLY.

CSLLY research

Overview

Company profile and research snapshot.

Company profile

CSL LTD SP/ADR

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Hold
Average target
$307.00
Implied upside
Analysts
4
CSLLY recent ratings
DateFirmRatingTarget
Jul 1, 2026BELL POTTER SECURITIESHold
Jun 29, 2026MACQUARIE RESEARCHNeutral
Jun 24, 2026JEFFERIESHold
May 12, 2026JEFFERIESBuy
May 11, 2026CANACCORD GENUITYHold
Open full forecast

News briefing

No generated briefing is available yet.

SeekingAlpha · Aug 13, 2026

Is CSL An Unmissable Value Play?

CSL (CSLLY) hold: attractive valuation vs peers, but guidance cuts and CEO turnover hurt visibility.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.